Clinical trial NCT04845906: A 7 Day Adhesive Device Wear Study to Evaluate BD StatLock™ Devices
Official title: A 7 Day Adhesive Device Wear Study to Evaluate BD StatLock™ Devices
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Peripheral Intravenous Catheter Stabilization
Lead sponsor: Becton, Dickinson and Company
Sponsor class: INDUSTRY
First posted: 2021-04-15
Enrollment: 120
Sex: ALL
Minimum age (years): 14
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Observational model: OTHER
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Potential participants will be recruited from healthy volunteer participant pools identified and/or held by the study site(s).

Brief summary: This study is a prospective healthy human volunteer wear study to evaluate the safety and performance of the StatLock™ Catheter Stabilization Device and the StatLock™ stabilization device Accessory (Foam Strip) and to meet the design input requirements.

Detailed description: This is a healthy human wear study of a minimum of 100 study participants who will wear the StatLock™ Catheter Stabilization Device and the StatLock™ stabilization device accessory (Foam Strip). Participants will report to the research center, on Day 0 to have their skin assessed by the investigator, clinician, and/or designee. On Day 0 the participants will have the StatLock™ Catheter Stabilization Devices and the foam strip applied. There will be 4 separate StatLock™ devices being tested, which will be randomly applied to the participants on their inner (ventral) forearms. Each participant will have 2 separate devices applied, one to each arm. Those participants who have the StatLock ™ Arterial Plus, StatLock™ Dialysis II, or the StatLock IV Select , will also have the Foam Strip applied.

The participant will also wear a dressing over top of a StatLock™ compatible catheter, which will be connected to an extension set. For this study, the catheter will not be inserted into the study participant but instead will be shortened or modified and placed on the skin and secured with the StatLock™ Stabilization Device. The catheter tip will be marked with indelible ink, to assess for any catheter movement. The use of the catheters, extension set, and the dressing represents how the device would be used in a clinical setting.

Once the devices are applied the participant will have the skin assessed (using a modified Draize Scale) by the investigator, clinician, and/or designee on Day 0. The participant will wear the devices at home for 1 week and will return on Day 7 for a skin assessment, evaluation of pad and foam strip lift, and catheter movement, evaluation of pain, and removal of the devices by the investigator, clinician, and/or designee. On Day 8, there may be a phone call and/or video call with the participant to review the skin condition of the site where the device was removed from.

Eligibility criteria: Inclusion Criteria:

* Any healthy human, 14 years of age or older, regardless of gender (Note: Consent of guardian or parent may be required for patients who are under 18 years of age).
* If they provide written and informed consent.
* Expected to be available for observation from consent, to the application on Day 0, and then removal of the StatLock™ Catheter Stabilization Device on Day 7, and for a follow up phone and/or video call on Day 8 for a skin assessment.
* Participant agrees to maintain a diary from device application, Day 0, through device removal, Day 7.
* Agree to keep the StatLock™ Catheter Stabilization Device, ancillary products, and site dry throughout the study
* Agrees to not use moisturizers, lotions, or any product labeled moisturizing for the duration of the study, at or around the site where the devices will be applied (inner (ventral) forearm).

Exclusion Criteria:

* If their skin was burned or scarred at the insertion site, or has any other skin condition which may affect the adherence and/or interpretation of the study results.
* If they have a known allergy to the study products (known tape or adhesive allergy).
* Has a medical condition which may prevent him or her from completing the study or place the study participant at undue risk.

Primary outcomes:
measure: Percent lift of the StatLock™ Catheter Stabilization Device Pad at Day 7
timeFrame: Day 7
measure: Percent of Device Movement of the StatLock™ Catheter Stabilization Device at Day 7
timeFrame: Day 7
measure: Ease of Removal of the StatLock™ Catheter Stabilization Device
timeFrame: Day 7
measure: Percent of participants with erythema score ≥ 2
timeFrame: Day 7
Secondary outcomes:
measure: Percent lift of the Foam Strip (StatLock™ Stabilization Device Accessory) at Day 7
timeFrame: Day 7
measure: Ease of Removal of the StatLock™ Stabilization Device Foam Strip
timeFrame: Day 7
measure: Level of pain upon removal of the StatLock™ Catheter Stabilization Device
timeFrame: Day 7
Other outcomes:
measure: Rate of StatLock™ Catheter Stabilization device-related adverse events
timeFrame: Day 0 to Day 8
Locations:
city: Fair Lawn
country: United States
facility: TKL Research, Inc
state: New Jersey
city: Broomall
country: United States
facility: Dermico, LLC
state: Pennsylvania
Study officials:
affiliation: TKL Research, Inc.
name: Michael Casser, MD
role: PRINCIPAL_INVESTIGATOR
affiliation: Dermico, LLC
name: Gary Grove, PhD
role: PRINCIPAL_INVESTIGATOR
References: